<DOC>
	<DOCNO>NCT02565173</DOCNO>
	<brief_summary>Phase III trial involve topical application , eye , trabodenoson ophthalmic formulation 3.0 % 6.0 % per day 4.5 % twice per day , placebo twice per day , timolol 0.5 % twice per day 12 week adult subject Ocular Hypertension Primary Open-Angle Glaucoma . All subject meet study 's enrollment criterion follow Screening undergo washout prohibit medication , include routine glaucoma medication . During Placebo Run-In Period , placebo administer twice daily eye subject . During Treatment Period , study drug apply eye total 12 week follow Observation Period approximately 7 day wherein study eye drop instill . The purpose study ass efficacy , tolerability , safety binocular topical application trabodenoson ophthalmic formulation 3.0 % 6.0 % QD 4.5 % BID 12 week . Timolol include trial order active control ensure integrity trial efficacy perspective ; primary comparator statistical purpose placebo arm .</brief_summary>
	<brief_title>Study Trabodenoson Adults With Ocular Hypertension Primary Open-angle Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Diagnosis ocular hypertension ( OHT ) primary openangle glaucoma ( POAG ) Mean Intraocular pressure ( IOP ) ≥24 ≤34 Significant visual field loss new field loss within past year Cuptodisc ratio &gt; 0.8 Central corneal thickness &lt; 490 µm &gt; 610 µm A recent ( acute ) chronic medical condition might obfuscate Subject 's study data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>primary open-angle glaucoma</keyword>
	<keyword>ocular hypertension</keyword>
	<keyword>adenosine agonist</keyword>
	<keyword>eye drop</keyword>
	<keyword>trabodenoson</keyword>
	<keyword>trabecular meshwork</keyword>
</DOC>